Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype

被引:36
作者
Hulette, BC
Rowden, G
Ryan, CA
Lawson, CM
Dawes, SM
Ridder, GM
Gerberick, GF
机构
[1] Procter & Gamble Co, Miami Valley Labs, Cincinnati, OH 45253 USA
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
关键词
dendritic cells; KG-1; Langerhans cells;
D O I
10.1007/s004030000201
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dendritic cells (DC) are highly specialized antigen-presenting cells located in many nonlymphoid tissues, and Langerhans cells (LC), a specialized form of DC, are found in the skin. LC as antigen-presenting cells play a critical role in the induction of allergic contact dermatitis, LC research is difficult because few LCs can be isolated from human skin, so efforts have focused on obtaining DCs from alternative sources. Mononuclear cells from peripheral blood and CD34(+) stem cells from human cord blood and marrow can be induced to form phenotypic and functional DCs, but experiments of this type are expensive and the DC yield is low. We report here the induction of the myeloid leukemia cell line (KG-1) to a DC morphology and phenotype by culturing the cells in a defined cytokine cocktail, Morphologically, the KG-1-derived DCs are large irregularly shaped cells with prominent dendritic processes and hair-like cytoplasmic projections, Phenotypically, the KG-1-derived DCs lack lineage-specific markers, and express MHC class II, costimulatory molecules CD80 and CD86, and CD83, Functionally, KG-1-derived DCs are capable of phagocytosing latex microspheres and are able to induce a potent allogeneic T-cell response. Within the KG-1-derived DCs, a subpopulation maintains the DC phenotype and morphology described above but further develops CD1a(+) marker expression similar to that of resident skin-derived LCs, These findings illustrate that phenotypic, morphologic andfunctional DCs can be derived from the KG-1 cell line.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 44 条
[1]  
CAUX C, 1995, J IMMUNOL, V155, P5427
[2]   RECENT ADVANCES IN THE STUDY OF DENDRITIC CELLS AND FOLLICULAR DENDRITIC CELLS [J].
CAUX, C ;
LIU, YJ ;
BANCHEREAU, J .
IMMUNOLOGY TODAY, 1995, 16 (01) :2-4
[3]   Respective involvement of TGF-β and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors [J].
Caux, C ;
Massacrier, C ;
Dubois, B ;
Valladeau, J ;
Dezutter-Dambuyant, C ;
Durand, I ;
Schmitt, D ;
Saeland, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :781-791
[4]   GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[5]   Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity [J].
Celluzzi, CM ;
Mayordomo, JI ;
Storkus, WJ ;
Lotze, MT ;
Falo, LD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :283-287
[6]   CD34+ acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells [J].
Cignetti, A ;
Bryant, E ;
Allione, B ;
Vitale, A ;
Foa, R ;
Cheever, MA .
BLOOD, 1999, 94 (06) :2048-2055
[7]   From Levinthal to pathways to funnels [J].
Dill, KA ;
Chan, HS .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (01) :10-19
[8]   REACTIVITY OF LANGERHANS CELLS WITH HYBRIDOMA ANTIBODY [J].
FITHIAN, E ;
KUNG, P ;
GOLDSTEIN, G ;
RUBENFELD, M ;
FENOGLIO, C ;
EDELSON, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (04) :2541-2544
[9]   LANGERHANS CELLS IN HUMAN ALLERGIC CONTACT-DERMATITIS CONTAIN VARYING NUMBERS OF BIRBECK GRANULES - DOUBLE STAINING IMMUNOHISTOCHEMISTRY WITH OKT6 AND LAG ANTIBODY [J].
FUJITA, M ;
KASHIHARASAWAMI, M ;
HORIGUCHI, Y ;
FURUKAWA, F ;
UEDA, M ;
IMAMURA, S .
HISTOCHEMISTRY, 1990, 94 (05) :497-504
[10]   Dendritic cells in antitumor immune responses .2. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors [J].
Gabrilovich, DI ;
Nadaf, S ;
Corak, J ;
Berzofsky, JA ;
Carbone, DP .
CELLULAR IMMUNOLOGY, 1996, 170 (01) :111-119